TATIANA KUTATELADZE

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. pmc Molecular basis for H3K36me3 recognition by the Tudor domain of PHF1
    Catherine A Musselman
    Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado, USA
    Nat Struct Mol Biol 19:1266-72. 2012
  2. pmc Molecular analysis of protein-phosphoinositide interactions
    Tatiana G Kutateladze
    Department of Pharmacology, University of Colorado Denver School of Medicine, Aurora, CO 80045, USA
    Curr Top Microbiol Immunol 362:111-26. 2012
  3. pmc Translation of the phosphoinositide code by PI effectors
    Tatiana G Kutateladze
    Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado, USA
    Nat Chem Biol 6:507-13. 2010
  4. pmc Handpicking epigenetic marks with PHD fingers
    Catherine A Musselman
    Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Nucleic Acids Res 39:9061-71. 2011

Research Grants

  1. Structural basis of signaling by ING2 PHD
    TATIANA KUTATELADZE; Fiscal Year: 2006
  2. Membrane Targeting by PI-binding Domains
    TATIANA KUTATELADZE; Fiscal Year: 2006
  3. Membrane Targeting by PI-binding Domains
    TATIANA KUTATELADZE; Fiscal Year: 2007
  4. Structural basis of signaling by ING2 PHD
    TATIANA KUTATELADZE; Fiscal Year: 2007
  5. Structural basis of signaling by ING2 PHD
    TATIANA KUTATELADZE; Fiscal Year: 2009
  6. Membrane Targeting by PI-binding Domains
    TATIANA KUTATELADZE; Fiscal Year: 2009
  7. Structural basis of signaling by ING2 PHD
    Tatiana G Kutateladze; Fiscal Year: 2010

Collaborators

  • Akira Yasui
  • Caroline A Kulesza
  • Catherine A Musselman
  • Zehui Hong
  • Marie Eve Lalonde
  • Christopher G Abraham
  • Reiko Watanabe
  • Jacques Cote
  • James K Nuñez
  • Jac Nickoloff
  • Nikita Avvakumov
  • Siddhartha Roy
  • Christopher Allen

Detail Information

Publications4

  1. pmc Molecular basis for H3K36me3 recognition by the Tudor domain of PHF1
    Catherine A Musselman
    Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado, USA
    Nat Struct Mol Biol 19:1266-72. 2012
    ..Together, our findings suggest that PHF1 can mediate deposition of the repressive H3K27me3 mark and acts as a cofactor in early DNA-damage response...
  2. pmc Molecular analysis of protein-phosphoinositide interactions
    Tatiana G Kutateladze
    Department of Pharmacology, University of Colorado Denver School of Medicine, Aurora, CO 80045, USA
    Curr Top Microbiol Immunol 362:111-26. 2012
    ..In this chapter, I summarize the mechanistic aspects of deciphering the 'PI code' by the most common PI-recognizing domains and discuss similarities and differences in the membrane anchoring mechanisms...
  3. pmc Translation of the phosphoinositide code by PI effectors
    Tatiana G Kutateladze
    Department of Pharmacology, University of Colorado School of Medicine, Aurora, Colorado, USA
    Nat Chem Biol 6:507-13. 2010
    ..In this review, I highlight the structural aspects of the deciphering of the 'PI code' by the most common PI-recognizing effectors and discuss the mechanistic details of their membrane anchoring...
  4. pmc Handpicking epigenetic marks with PHD fingers
    Catherine A Musselman
    Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA
    Nucleic Acids Res 39:9061-71. 2011
    ..We discuss the significance of crosstalk between the histone modifications and consequences of combinatorial readout for selective recruitment of the PHD finger-containing components of chromatin remodeling and transcriptional complexes...

Research Grants9

  1. Structural basis of signaling by ING2 PHD
    TATIANA KUTATELADZE; Fiscal Year: 2006
    ..These studies will aid in deeper understanding of how the critical ING2-p53 pathways can be therapeutically manipulated and may help to identify new diagnostic markers and targets to prevent and treat cancer. ..
  2. Membrane Targeting by PI-binding Domains
    TATIANA KUTATELADZE; Fiscal Year: 2006
    ..The results generated by this research may provide new approaches to rational design of anti-tumor therapeutic agents and systems for delivering drugs into cancer cells. ..
  3. Membrane Targeting by PI-binding Domains
    TATIANA KUTATELADZE; Fiscal Year: 2007
    ..The results generated by this research may provide new approaches to rational design of anti-tumor therapeutic agents and systems for delivering drugs into cancer cells. ..
  4. Structural basis of signaling by ING2 PHD
    TATIANA KUTATELADZE; Fiscal Year: 2007
    ..These studies will aid in deeper understanding of how the critical ING2-p53 pathways can be therapeutically manipulated and may help to identify new diagnostic markers and targets to prevent and treat cancer. ..
  5. Structural basis of signaling by ING2 PHD
    TATIANA KUTATELADZE; Fiscal Year: 2009
    ..These studies will aid in deeper understanding of how the critical ING2-p53 pathways can be therapeutically manipulated and may help to identify new diagnostic markers and targets to prevent and treat cancer. ..
  6. Membrane Targeting by PI-binding Domains
    TATIANA KUTATELADZE; Fiscal Year: 2009
    ..The results generated by this research may provide new approaches to rational design of anti-tumor therapeutic agents and systems for delivering drugs into cancer cells. ..
  7. Structural basis of signaling by ING2 PHD
    Tatiana G Kutateladze; Fiscal Year: 2010
    ..These studies will aid in deeper understanding of how the critical ING2-p53 pathways can be therapeutically manipulated and may help to identify new diagnostic markers and targets to prevent and treat cancer. ..